|
|
|
Insider
Information: |
Mammen Mathai |
Relationship: |
EVP, Pharm, R&D |
City: |
South San Francisco |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
4 |
|
Direct
Shares |
835,695 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$14,395,469 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
835,695 |
|
|
Total
Value |
$14,395,469 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Innoviva Inc |
INVA |
SVP, Research & Early ... |
2014-08-20 |
334,040 |
|
0 |
Premium* |
|
Theravance Biopharma, Inc. |
TBPH |
SVP, Research & Develo... |
2016-03-15 |
288,111 |
|
0 |
Premium* |
|
10x Genomics, Inc. |
TXG |
|
2023-06-14 |
171,610 |
2021-06-11 |
0 |
Premium* |
|
Johnson & Johnson |
JNJ |
EVP, Pharm, R&D |
2022-02-15 |
41,934 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
75 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
INVA |
Innoviva Inc |
SVP, Research & Early Clin Dev |
|
2012-12-31 |
4 |
GD |
$0.00 |
$0 |
D/D |
460 |
219,978 |
0 |
- |
|
INVA |
Innoviva Inc |
SVP, Research & Early Clin Dev |
|
2013-01-11 |
4 |
OE |
$3.10 |
$44,981 |
D/D |
14,510 |
220,438 |
0 |
- |
|
INVA |
Innoviva Inc |
SVP, Research & Early Clin Dev |
|
2013-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
224,978 |
0 |
- |
|
INVA |
Innoviva Inc |
SVP, Research & Early Clin Dev |
|
2013-02-20 |
4 |
D |
$22.10 |
$110,544 |
D/D |
(5,002) |
219,976 |
0 |
- |
|
INVA |
Innoviva Inc |
SVP, Research & Early Clin Dev |
|
2013-02-20 |
4 |
AS |
$22.14 |
$154,980 |
D/D |
(7,000) |
212,976 |
0 |
- |
|
INVA |
Innoviva Inc |
SVP, Research & Early Clin Dev |
|
2013-04-30 |
4 |
AS |
$33.72 |
$236,164 |
D/D |
(7,000) |
205,976 |
0 |
- |
|
INVA |
Innoviva Inc |
SVP, Research & Early Clin Dev |
|
2013-05-20 |
4 |
D |
$37.01 |
$121,837 |
D/D |
(3,292) |
202,684 |
0 |
- |
|
INVA |
Innoviva Inc |
SVP, Research & Early Clin Dev |
|
2013-05-29 |
4 |
OE |
$3.10 |
$94,159 |
D/D |
11,021 |
213,705 |
0 |
- |
|
INVA |
Innoviva Inc |
SVP, Research & Early Clin Dev |
|
2013-07-24 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
218,705 |
0 |
- |
|
INVA |
Innoviva Inc |
SVP, Research & Early Clin Dev |
|
2013-07-30 |
4 |
AS |
$36.51 |
$255,570 |
D/D |
(7,000) |
211,705 |
0 |
- |
|
INVA |
Innoviva Inc |
SVP, Research & Early Clin Dev |
|
2013-08-20 |
4 |
D |
$35.89 |
$136,849 |
D/D |
(3,813) |
207,892 |
0 |
- |
|
INVA |
Innoviva Inc |
SVP, Research & Early Clin Dev |
|
2013-08-21 |
4 |
OE |
$16.00 |
$300,000 |
D/D |
18,750 |
226,642 |
0 |
- |
|
INVA |
Innoviva Inc |
SVP, Research & Early Clin Dev |
|
2013-10-03 |
5 |
GD |
$0.00 |
$0 |
D/D |
450 |
221,623 |
0 |
- |
|
INVA |
Innoviva Inc |
SVP, Research & Early Clin Dev |
|
2013-11-20 |
4 |
D |
$36.40 |
$166,312 |
D/D |
(4,569) |
222,073 |
0 |
- |
|
INVA |
Innoviva Inc |
SVP, Research & Early Clin Dev |
|
2014-02-14 |
4 |
AS |
$39.26 |
$1,377,688 |
D/D |
(35,000) |
186,623 |
0 |
- |
|
INVA |
Innoviva Inc |
SVP, Research & Early Clin Dev |
|
2014-02-20 |
4 |
D |
$39.98 |
$172,194 |
D/D |
(4,307) |
182,316 |
0 |
- |
|
INVA |
Innoviva Inc |
SVP, Research & Early Clin Dev |
|
2014-03-06 |
4 |
OE |
$12.40 |
$627,997 |
D/D |
42,153 |
224,469 |
0 |
- |
|
INVA |
Innoviva Inc |
SVP, Research & Early Clin Dev |
|
2014-03-13 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,200 |
237,936 |
0 |
- |
|
INVA |
Innoviva Inc |
SVP, Research & Early Clin Dev |
|
2014-04-27 |
4 |
A |
$0.00 |
$0 |
D/D |
37,500 |
261,969 |
0 |
- |
|
INVA |
Innoviva Inc |
SVP, Research & Early Clin Dev |
|
2014-05-09 |
4 |
D |
$26.86 |
$613,294 |
D/D |
(22,833) |
239,136 |
0 |
- |
|
INVA |
Innoviva Inc |
SVP, Research & Early Clin Dev |
|
2014-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
71,000 |
308,936 |
0 |
- |
|
INVA |
Innoviva Inc |
SVP, Research & Early Clin Dev |
|
2014-06-16 |
4 |
A |
$0.00 |
$0 |
D/D |
28,365 |
337,301 |
0 |
- |
|
INVA |
Innoviva Inc |
SVP, Research & Early Clin Dev |
|
2014-08-20 |
4 |
D |
$22.76 |
$74,220 |
D/D |
(3,261) |
334,040 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
SVP, Research & Early Clin Dev |
|
2014-10-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
81,150 |
|
- |
|
TBPH |
Theravance Biopharma, Inc... |
SVP, Research & Early Clin Dev |
|
2014-11-20 |
4 |
D |
$0.00 |
$0 |
D/D |
(658) |
80,492 |
0 |
- |
|
75 Records found
|
|
Page 3 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|